HALO

Halozyme Therapeutics, Inc.

HealthcareBiotechnologyUSUSD

$68.14

LiveJun 01, 2026

Market cap

$8.08B

52w range

51.06 – 82.22

P / E

—

EPS

—

Volume

2.34M

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on Halozyme Therapeutics, Inc.’s valuation

Corporate actions combine splits (live, full history), symbol changes (refreshed weekly), the daily M&A wire, and 13D/G filings.